The effects of somatostatin in the polycystic ovary syndrome (Q47968939)

7 February 2018

title

The effects of somatostatin in the polycystic ovary syndrome (English)

1 reference

7 February 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

Rosina B

1 reference

7 February 2018

De Fusco D

series ordinal

1 reference

7 February 2018

Falsetti L

series ordinal

1 reference

7 February 2018

publication date

1 November 1997

1 reference

7 February 2018

Journal of Obstetrics and Gynaecology

published in

1 reference

7 February 2018

volume

1 reference

7 February 2018

issue

1 reference

7 February 2018

page(s)

560-564

1 reference

7 February 2018

Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

Cellular mechanisms of insulin resistance in polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

Polycystic ovaries--a common finding in normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

Sensitivity of plasma insulin levels in obese and non-obese women with functional hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443619768614

21 January 2018

Identifiers

DOI

10.1080/01443619768614

1 reference

7 February 2018

release_urppmtektvaqrjoysxrpfptqq4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/urppmtektvaqrjoysxrpfptqq4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

7 February 2018